{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T23:36:35Z","timestamp":1774049795142,"version":"3.50.1"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T00:00:00Z","timestamp":1679356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Temporal arteritis (TA) is a large-vessel vasculitis mostly seen in older patients. Amyloid A (AA) amyloidosis secondary to a chronic inflammation induces multiple organ dysfunctions, including a dysfunction of the gastrointestinal tract. Herein, we present a case of TA complicated by AA amyloidosis that was resistant to oral and intravenous steroids. An 80-year-old man with a history of new-onset headache, jaw claudication, and distended temporal arteries was referred to our department. On admission, the patient presented with tenderness and a subcutaneous temporal nodule in both temple arteries. Ultrasonography of the nodule revealed an anechoic perivascular halo surrounding the right temporal artery. Following the diagnosis of TA, high-dose prednisolone therapy was initiated. However, the patient presented with recurrent abdominal pain and refractory diarrhea. Due to the unclear origin of refractory diarrhea, an extensive workup, including biopsy of the duodenal mucosa, was performed. Endoscopy revealed chronic inflammation in the duodenum. Immunohistochemical analysis of duodenal mucosal biopsy samples revealed AA amyloid deposition resulting in the diagnosis of AA amyloidosis. After tocilizumab (TCZ) administration, refractory diarrhea reduced; however, the patient died of intestinal perforation 1 month after the start of TCZ administration. Gastrointestinal involvement was the main clinical manifestation of AA amyloidosis in the present case. This case highlights the importance of bowel biopsy screening for amyloid deposition in patients with unexplained gastrointestinal tract symptoms, even in a recent onset of large-vessel vasculitis. In the present case, the carriage of the <jats:italic>SAA1.3<\/jats:italic> allele likely contributed to the rare association of AA amyloidosis with TA.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1144397","type":"journal-article","created":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T06:21:18Z","timestamp":1679379678000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Case report: Rapid development of amyloid A amyloidosis in temporal arteritis with SAA1.3 allele; An unusual case of intestinal amyloidosis secondary to temporal arteritis"],"prefix":"10.3389","volume":"14","author":[{"given":"Shuhei","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jumpei","family":"Temmoku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norshalena","family":"Shakespear","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Kiko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Sumichika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Asano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuzo","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromasa","family":"Ohira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Migita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2013.0376","article-title":"The diagnosis and treatment of giant cell arteritis","volume":"110","author":"Ness","year":"2013","journal-title":"Dtsch Arztebl Int"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra023144","article-title":"Molecular mechanisms of amyloidosis","volume":"349","author":"Merlini","year":"2003","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3109\/13506129.2014.964858","article-title":"Nomenclature 2014: Amyloid fibril proteins and clinical classification of the amyloidosis","volume":"21","author":"Sipe","year":"2014","journal-title":"Amyloid"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.286.6375.1391","article-title":"Correlation of persistently high serum amyloid a protein and c-reactive protein concentrations with rapid progression of secondary amyloidosis","volume":"286","author":"Falck","year":"1983","journal-title":"Br Med J (Clin Res Ed)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(00)05252-1","article-title":"Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid a protein","volume":"358","author":"Gillmore","year":"2001","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa070265","article-title":"Natural history and outcome in systemic AA amyloidosis","volume":"356","author":"Lachmann","year":"2007","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1080\/03009740151095448","article-title":"Giant cell arteritis and secondary amyloidosis: The natural history","volume":"30","author":"Altiparmak","year":"2001","journal-title":"Scand J Rheumatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/4.6.1083","article-title":"A novel allelic variant of serum amyloid a, SAA1 gamma: Genomic evidence, evolution, frequency, and implication as a risk factor for reactive systemic AA-amyloidosis","volume":"4","author":"Baba","year":"1995","journal-title":"Hum Mol Genet"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200106)44:6<1266::Aid-art218>3.0.Co;2-3","article-title":"A novel single-nucleotide polymorphism at the 5'-flanking region of SAA1 associated with risk of type AA amyloidosis secondary to rheumatoid arthritis","volume":"44","author":"Moriguchi","year":"2001","journal-title":"Arthritis Rheum"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2011.10.012","article-title":"Homozygous M694V as a risk factor for amyloidosis in Turkish FMF patients","volume":"492","author":"Akpolat","year":"2012","journal-title":"Gene"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kei112","article-title":"Significance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis","volume":"45","author":"Nakamura","year":"2006","journal-title":"Rheumatol (Oxford)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s10165-006-0500-8","article-title":"SAA1 gene polymorphisms and the risk of AA amyloidosis in Japanese patients with rheumatoid arthritis","volume":"16","author":"Ajiro","year":"2006","journal-title":"Mod Rheumatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223480","article-title":"American College of Rheumatology\/EULAR classification criteria for giant cell arteritis","volume":"81","author":"Ponte","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000013394","article-title":"Serum amyloid A1 (SAA1) gene polymorphisms in Japanese patients with adult-onset still's disease","volume":"97","author":"Yashiro","year":"2018","journal-title":"Med (Baltimore)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199107000-00002","article-title":"Secondary systemic amyloidosis: Response and survival in 64 patients","volume":"70","author":"Gertz","year":"1991","journal-title":"Med (Baltimore)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11926-021-00980-5","article-title":"Blood biomarkers for monitoring and prognosis of Large vessel vasculitides","volume":"23","author":"Tombetti","year":"2021","journal-title":"Curr Rheumatol Rep"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/35.1.44","article-title":"Secondary amyloidosis in patients with rheumatoid arthritis: Diagnostic and prognostic value of gastroduodenal biopsy","volume":"35","author":"Kobayashi","year":"1996","journal-title":"Br J Rheumatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3109\/13506129.2013.840576","article-title":"Turkish Experience in rheumatoid arthritis patients with clinical apparent amyloid deposition","volume":"20","author":"Pamuk","year":"2013","journal-title":"Amyloid"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/0925-4439(94)00076-3","article-title":"Characterization of amyloid a protein in human secondary amyloidosis: The predominant deposition of serum amyloid A1","volume":"1270","author":"Liepnieks","year":"1995","journal-title":"Biochim Biophys Acta"},{"key":"B20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.gene.2016.02.044","article-title":"Serum amyloid A1: Structure, function and gene polymorphism","volume":"583","author":"Sun","year":"2016","journal-title":"Gene"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s004399900150","article-title":"Influence of genotypes at SAA1 and SAA2 loci on the development and the length of latent period of secondary AA-amyloidosis in patients with rheumatoid arthritis","volume":"105","author":"Moriguchi","year":"1999","journal-title":"Hum Genet"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3109\/13506129.2011.582198","article-title":"Ageing: a risk factor for amyloid a amyloidosis in rheumatoid arthritis","volume":"18","author":"Okuda","year":"2011","journal-title":"Amyloid"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/s0950-3579(05)80121-9","article-title":"Clinical and therapeutic aspects of AA amyloidosis","volume":"8","author":"Hazenberg","year":"1994","journal-title":"Baillieres Clin Rheumatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2003.12.096","article-title":"IL-6 plays a critical role in the synergistic induction of human serum amyloid a (SAA) gene when stimulated with proinflammatory cytokines as analyzed with an SAA isoform real-time quantitative RT-PCR assay system","volume":"314","author":"Hagihara","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2443.2005.00900.x","article-title":"Essential role of STAT3 in cytokine-driven NF-kappaB-mediated serum amyloid a gene expression","volume":"10","author":"Hagihara","year":"2005","journal-title":"Genes Cells"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3109\/14397595.2013.854048","article-title":"Comparison of the clinical utility of tocilizumab and anti-TNF therapy in AA amyloidosis complicating rheumatic diseases","volume":"24","author":"Okuda","year":"2014","journal-title":"Mod Rheumatol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"54","DOI":"10.5414\/cn109971","article-title":"Tocilizumab preserves renal function in rheumatoid arthritis with AA amyloidosis and end-stage kidney disease: Two case reports","volume":"95","author":"Fukuda","year":"2021","journal-title":"Clin Nephrol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/art.11388","article-title":"Glucocorticoid therapy in giant cell arteritis: Duration and adverse outcomes","volume":"49","author":"Proven","year":"2003","journal-title":"Arthritis Rheum"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1613849","article-title":"Trial of tocilizumab in giant-cell arteritis","volume":"377","author":"Stone","year":"2017","journal-title":"N Engl J Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"R141","DOI":"10.1186\/ar3455","article-title":"Integrated safety in tocilizumab clinical trials","volume":"13","author":"Schiff","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key207","article-title":"The British society for rheumatology biologic DMARD safety guidelines in inflammatory arthritis-executive summary","volume":"58","author":"Holroyd","year":"2019","journal-title":"Rheumatol (Oxford)"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-011-1827-x","article-title":"Lower gastrointestinal perforation in rheumatoid arthritis patients treated with conventional DMARDs or tocilizumab: A systematic literature review","volume":"30","author":"Gout","year":"2011","journal-title":"Clin Rheumatol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-009-1185-0","article-title":"Tocilizumab dramatically ameliorated life-threatening diarrhea due to secondary amyloidosis associated with rheumatoid arthritis","volume":"28","author":"Sato","year":"2009","journal-title":"Clin Rheumatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1144397\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T06:21:19Z","timestamp":1679379679000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1144397\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,21]]},"references-count":33,"alternative-id":["10.3389\/fimmu.2023.1144397"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1144397","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,21]]},"article-number":"1144397"}}